Entourage_logo (002).jpg
Entourage Health Reports Third Quarter 2023 Financial Results and Posts $12.2 Million in Total Revenue
28 nov. 2023 07h45 HE | Entourage Health Corp.
Entourage sees the benefits of transitioning from cultivation and reports over $10 million to date in annualized cost savings.Gross Profit Before Fair Value Changes has surged to $2.4 million,...
Entourage_logo (002).jpg
Entourage Health to Host Third Quarter 2023 Financial Results Call on November 28
08 nov. 2023 07h00 HE | Entourage Health Corp.
TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage_logo (002).jpg
Entourage Health Reports Second Quarter 2023 Financial Results
30 août 2023 07h41 HE | Entourage Health Corp.
The Company achieved a total revenue of $13.3 million, driven by an 8% increase in adult-use revenue and a significant 45% increase in pre-roll revenue year-over-yearGross Profit Before Fair Value...
Entourage_logo (002).jpg
Entourage Health to Host First Quarter 2023 Earnings Conference Call
15 mai 2023 07h30 HE | Entourage Health Corp.
Company financials to be filed after market on May 29, 2023, and operational outlook to be provided during call, including milestones achieved. Company announces issuance of 1,423,057 common shares...
Entourage_logo (002).jpg
Entourage Health Reports Fiscal Year 2022 Financial Results and Posts $54.5 Million in Total Revenues
01 mai 2023 19h52 HE | Entourage Health Corp.
Record net medical revenue of $17.4 million for 2022, representing 16% growthEntourage secured a 5% share of total sales, ranking them in the fourth spot of national pre-roll sales in 2022Upsized...
Entourage_logo (002).jpg
Entourage Health Reschedules Full-Year 2022 Earnings Conference Call to Align with First Quarter 2023 Results
21 avr. 2023 16h00 HE | Entourage Health Corp.
TORONTO, April 21, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...
Entourage_logo (002).jpg
Entourage Health Announces Timing of Fiscal Year End 2022 Conference Call for April 28
14 avr. 2023 07h35 HE | Entourage Health Corp.
TORONTO, April 14, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...
Entourage_logo (002).jpg
Entourage Health Reports Third Quarter 2022 Financial Results and Posts $13.4 Million in Total Revenue
15 nov. 2022 08h20 HE | Entourage Health Corp.
Company signs three-year supply agreement with HEXO Corp. to buy bulk cannabis for its expanding retail distribution and increased medical offeringsEntourage to transition away from cultivation as it...
Entourage_logo (002).jpg
Entourage Health to Host Third Quarter 2022 Financial Results Call on November 15
08 nov. 2022 07h30 HE | Entourage Health Corp.
TORONTO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage_logo (002).jpg
Entourage Health Reports Second Quarter 2022 Financial Results
29 août 2022 09h49 HE | Entourage Health Corp.
TORONTO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...